Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/4/2025
Genscript Secures NMPA IND Clearance for Second Bispecific ADC GenSci1...
11/4/2025
Abbisko Begins Phase II Trial of Oral PD-L1 Inhibitor ABSK043 in Combo...
11/4/2025
Everest Acquires Exclusive Greater China and Other Asian Country Right...
11/4/2025
CStone Receives NMPA IND Approval for Phase II Trials of CS2009
11/4/2025
China to Include HPV Vaccines in National Immunization Program
11/4/2025
Lupeng Pharma's Hong Kong IPO Application Accepted
11/4/2025
Alebund Pharma's Hong Kong IPO Application Accepted
11/4/2025
NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO
11/4/2025
Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
11/4/2025
Lepu Licenses GLP-1/GIP/FGF21 Agonist MWN105 to Sidera in US$1.05B Dea...
11/4/2025
CDE Seeks Comments on the 100th Batch of Reference Formulations for Ch...
11/4/2025
CDE Invites Comments on the Draft Technical Guidelines for Dose Extrap...
11/4/2025
NHSA Introduces New Measure to Strengthen Intelligent Oversight of Exc...
11/4/2025
China's BMI Fund Maintains Strong Surplus in First Three Quarters of 2...
10/31/2025
NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin
10/31/2025
Asia Regenerative Medicine Completes Series A Funding
10/31/2025
Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...
10/31/2025
Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...
10/31/2025
Longwood Biopharma Secures Series B+ Funding to Accelerate Innovative ...
10/31/2025
Roche Strikes Over $1B Global Licensing Deal with Qyuns Therapeutics
10/31/2025
Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...
10/31/2025
Lumosa's Stroke Drug Achieves Phase IIb Success in China
10/31/2025
China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...
10/31/2025
China Overhauls Drug Procurement and Reimbursement Framework to Balanc...
10/31/2025
Haleon Gains Momentum in China as U.S. Sales Remain Weak
10/31/2025
GC Cell Licenses IASO Biotech's Multiple Myeloma CAR-T Therapy for Kor...
10/31/2025
CDE Invites Comment on Implementation Guidance for ICH Q8, Q9 and Q10 ...
10/31/2025
China's Biotech Deal Boom Tests Ethical Boundaries as Valuations Soar ...
10/29/2025
China Pushes Ethical Limits in Global Biotech Race With Gene-Edited An...
10/29/2025
Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...
Page:
1
/
798
Total number of articles:
23912
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit